eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
corinna's twin boys -- maarten, left, and linus -- were the first humans to be treated for their genetic disorder while still inside the womb..one woman's migraine story..